Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastoma

MD Blough, DC Beauchamp, MR Westgate… - Journal of neuro …, 2011 - Springer
The most effective chemotherapeutic for glioblastoma (GBM) is the DNA alkylating agent
temozolomide (TMZ). In a recent study by Hegi et al. benefit from TMZ was significantly …

Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastoma

MD Blough, DC Beauchamp… - Journal of neuro …, 2011 - pubmed.ncbi.nlm.nih.gov
The most effective chemotherapeutic for glioblastoma (GBM) is the DNA alkylating agent
temozolomide (TMZ). In a recent study by Hegi et al. benefit from TMZ was significantly …

Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastoma.

MD Blough, DC Beauchamp, MR Westgate… - Journal of Neuro …, 2010 - europepmc.org
The most effective chemotherapeutic for glioblastoma (GBM) is the DNA alkylating agent
temozolomide (TMZ). In a recent study by Hegi et al. benefit from TMZ was significantly …

Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastoma

MD Blough, DC Beauchamp… - Journal of Neuro …, 2011 - search.proquest.com
The most effective chemotherapeutic for glioblastoma (GBM) is the DNA alkylating agent
temozolomide (TMZ). In a recent study by Hegi et al. benefit from TMZ was significantly …

Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastoma

MD Blough, DC Beauchamp, MR Westgate… - Journal of Neuro …, 2011 - infona.pl
The most effective chemotherapeutic for glioblastoma (GBM) is the DNA alkylating agent
temozolomide (TMZ). In a recent study by Hegi et al. benefit from TMZ was significantly …

[引用][C] Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastoma

MD Blough, DC Beauchamp, MR Westgate… - Journal of Neuro …, 2010 - cir.nii.ac.jp
Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor
initiating cells from glioblastoma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …

Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastoma.

M Blough, D Beauchamp, M Westgate… - Journal of Neuro …, 2011 - search.ebscohost.com
The most effective chemotherapeutic for glioblastoma (GBM) is the DNA alkylating agent
temozolomide (TMZ). In a recent study by Hegi et al. benefit from TMZ was significantly …

Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastoma.

M Blough, D Beauchamp, M Westgate… - Journal of Neuro …, 2011 - search.ebscohost.com
The most effective chemotherapeutic for glioblastoma (GBM) is the DNA alkylating agent
temozolomide (TMZ). In a recent study by Hegi et al. benefit from TMZ was significantly …

Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastoma

MD Blough, DC Beauchamp, MR Westgate… - Journal of Neuro …, 2011 - infona.pl
The most effective chemotherapeutic for glioblastoma (GBM) is the DNA alkylating agent
temozolomide (TMZ). In a recent study by Hegi et al. benefit from TMZ was significantly …

[引用][C] Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastoma

MD Blough, DC Beauchamp, MR Westgate… - Journal of Neuro …, 2011 - Springer